NR1H4 and inflammatory bowel disease: Dysregulation of the FXR acetyl/SUMO switch may be the general mechanism by which anti-inflammatory responses of other transcriptional regulators are reduced, and may supply potential salutary and diagnostic methods for IBD and some inflammatory-related metabolic illnesses (Kim et al., 2015).